169 related articles for article (PubMed ID: 10740048)
1. [Lyell's syndrome and its ophthalmologic manifestations in Cameroon].
Moussala M; Beharcohen F; Dighiero P; Renard G
J Fr Ophtalmol; 2000 Mar; 23(3):229-37. PubMed ID: 10740048
[TBL] [Abstract][Full Text] [Related]
2. [Ocular manifestations and sequelae of Lyell syndrome caused by sulfadoxine-pyrimethamine in Cameroon].
Moussala M; Binam F; Nkam M; Kouda Zeh A; Bengono G
J Fr Ophtalmol; 1998 Jan; 21(1):72-7. PubMed ID: 9834901
[TBL] [Abstract][Full Text] [Related]
3. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).
Guillaume JC; Roujeau JC; Revuz J; Penso D; Touraine R
Arch Dermatol; 1987 Sep; 123(9):1166-70. PubMed ID: 3632001
[TBL] [Abstract][Full Text] [Related]
4. [Ocular complications of Lyell's syndrome: recent concepts apropos of 26 cases].
Binaghi M; Koso M; Roujeau JC; Coscas G
J Fr Ophtalmol; 1985; 8(3):239-43. PubMed ID: 4056315
[TBL] [Abstract][Full Text] [Related]
5. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ukponmwan CU; Njinaka I; Ehimiyen ET
Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
[TBL] [Abstract][Full Text] [Related]
6. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
7. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
9. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
Ugburo AO; Temiye EO; Ilombu CA
Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin-induced toxic epidermal necrolysis: a case report.
Creamer JD; Whittaker SJ; Kerr-Muir M; Smith NP
Clin Exp Dermatol; 1996 Mar; 21(2):116-20. PubMed ID: 8759197
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
[TBL] [Abstract][Full Text] [Related]
13. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement.
Kobayashi A; Yoshita T; Sugiyama K; Miyashita K; Niida Y; Koizumi S; Tseng SC
Ophthalmology; 2006 Jan; 113(1):126-32. PubMed ID: 16324747
[TBL] [Abstract][Full Text] [Related]
14. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
15. [Lyell's syndrome(ocular complications)].
Corcelle L; Battin J; Lacassin JM; Roques M
Bull Soc Ophtalmol Fr; 1972; 72(9):965-9. PubMed ID: 4666380
[No Abstract] [Full Text] [Related]
16. [Drugs involved in toxic epidermal necrolysis (Lyell's syndrome)].
Paquet P
Therapie; 1993; 48(2):133-9. PubMed ID: 8351682
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced Lyell and Stevens-Johnson syndromes.
Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
[TBL] [Abstract][Full Text] [Related]
18. [Oculocutaneous syndromes of toxic origin: Lyell's syndrome].
Michiels J
Bull Soc Belge Ophtalmol; 1972; 160(1):487-503. PubMed ID: 5047229
[No Abstract] [Full Text] [Related]
19. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
[TBL] [Abstract][Full Text] [Related]
20. [Ocular involvement in Lyell's syndrome. Incidence, evolution, prognosis].
Binaghi M; Koso M; Saiag P; Roujeau JC; Coscas G
Ophtalmologie; 1988; 2(2):121-2. PubMed ID: 3247145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
